Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.
about
Chemotherapy and chemoprevention by thiazolidinedionesAn Integrated Genome-Wide Systems Genetics Screen for Breast Cancer Metastasis Susceptibility GenesAn open letter to the FDA and other regulatory agencies: Preclinical drug development must consider the impact on metastasis.Effect of troglitazone on tumor growth and pulmonary metastasis development of the mouse osteosarcoma cell line LM8The investigation of mitogen-activated protein kinase phosphatase-1 as a potential pharmacological target in non-small cell lung carcinomas, assisted by non-invasive molecular imagingTherapeutic Implications of PPARgamma in Human Osteosarcoma.Matrix metalloproteinase-9 is increased in obese subjects and decreases in response to pioglitazoneHigh antimetastatic efficacy of MEN4901/T-0128, a novel camptothecin carboxymethyldextran conjugateCohort study of pioglitazone and cancer incidence in patients with diabetesInhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration.Pioglitazone induces a proadipogenic antitumor response in mice with PAX8-PPARgamma fusion protein thyroid carcinoma.Pretreatment of BMSCs with TZD solution decreases the proliferation rate of MCF‑7 cells by reducing FGF4 protein expression.PPAR Ligands as Potential Modifiers of Breast Carcinoma Outcomes.Phenylbutyrate induces apoptosis and lipid accumulations via a peroxisome proliferator-activated receptor gamma-dependent pathway.Rosiglitazone as an option for patients with acromegaly: a case series.Troglitazone inhibits the migration and invasion of PC-3 human prostate cancer cells by upregulating E-cadherin and glutathione peroxidase 3
P2860
Q27011352-D9E2E719-432A-41A5-86E3-9D14554B9AE8Q27308942-421D098F-2C6F-4D85-824E-B3A2EFD05193Q30410564-22F3A7F9-C062-40DB-9B28-3933BA90F23DQ33532809-B3809DE1-B1BD-4802-94EF-4B085E08B290Q33540291-25AB9551-B84E-442A-8641-4203E8A32F82Q33674615-1B65130E-EC20-4426-AC1D-9CEC0483A6C0Q33984832-B0F83543-584F-4843-8B10-114808842335Q34432610-4465913A-7C6B-429C-88BF-29767714FA90Q34718437-C20160EB-E5E8-4B7B-B410-4C13A0DF26FBQ35313033-3448F567-7BB5-4D12-9BED-12E6A202FA99Q35417323-F686CFDB-A6C5-4DC2-99AF-C6585FBE76BBQ36722145-1B8D8967-68F9-41CE-AE01-5B9B6FEA49E1Q36772391-A5E45B55-229C-460B-B9C6-F4CC5CCD0541Q39728530-5518615E-3D68-463E-91DC-A8530974B3D5Q42759245-1C2B07DC-BC18-45C2-9F21-195CDDE09636Q58794883-CFCEDC2C-97DA-443A-8D45-15922B354840
P2860
Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.
@ast
Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.
@en
Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.
@nl
type
label
Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.
@ast
Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.
@en
Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.
@nl
prefLabel
Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.
@ast
Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.
@en
Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.
@nl
P2093
P2860
P356
P1433
P1476
Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.
@en
P2093
Gabriela Magenta
María Adela Jasnis
Romina Rolando
Ximena Borenstein
P2860
P2888
P356
10.1186/1471-2407-8-47
P407
P577
2008-02-08T00:00:00Z
P5875
P6179
1045341717